|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent NVAX insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why NVAX insider buys are important for investors to follow.
Date | Insider | Price | Amount |
3-10-2023 Insider Buy |
Gregory M. Glenn President, R&D |
$7.17
CAGR »
|
$43,041.50 6,000 shares |
6-3-2020 Insider Buy |
James F. Young Director |
$48.83
CAGR »
|
$73,245.00 1,500 shares |
1-31-2020 Insider Buy |
Gregory M. Glenn President, R&D |
$3.86
CAGR »
|
$4,825.00 1,250 shares |
5-13-2019 Insider Buy |
Gregory M. Glenn President, R&D |
$5.85
CAGR »
|
$5,849.90 1,000 shares |
1-31-2019 Insider Buy |
Gregory M. Glenn President, R&D |
$0.88
CAGR »
|
$11,587.84 13,168 shares |
7-31-2018 Insider Buy |
Gregory M. Glenn President, R&D |
$0.88
CAGR »
|
$11,446.16 13,007 shares |
5-14-2018 Insider Buy |
Gregory M. Glenn President, R&D |
$1.64
CAGR »
|
$32,799.50 20,000 shares |
5-14-2018 Insider Buy |
Stanley C. Erck President and CEO |
$1.65
CAGR »
|
$164,620.00 100,000 shares |
1-31-2018 Insider Buy |
Gregory M. Glenn President, R&D |
$0.88
CAGR »
|
$11,249.92 12,784 shares |
11-9-2017 Insider Buy |
Stanley C. Erck President and CEO |
$1.13
CAGR »
|
$113,050.00 100,000 shares |
11-9-2017 Insider Buy |
Gregory M. Glenn President, R&D |
$1.13
CAGR »
|
$11,300.00 10,000 shares |
7-31-2017 Insider Buy |
Barclay A. Phillips SVP, Chief Financial Officer |
$0.89
CAGR »
|
$1,830.73 2,057 shares |
5-11-2017 Insider Buy |
Richard Douglas Director |
$0.93
CAGR »
|
$185,780.00 200,000 shares |
5-11-2017 Insider Buy |
Barclay A. Phillips SVP, Chief Financial Officer |
$0.84
CAGR »
|
$20,950.00 25,000 shares |
5-11-2017 Insider Buy |
Stanley C. Erck President and CEO |
$0.84
CAGR »
|
$41,980.00 50,000 shares |
1-31-2017 Insider Buy |
Barclay A. Phillips SVP, Chief Financial Officer |
$1.12
CAGR »
|
$1,828.96 1,633 shares |
1-31-2017 Insider Buy |
John A. Herrmann III SVP, General Counsel |
$1.12
CAGR »
|
$5,555.20 4,960 shares |
1-31-2017 Insider Buy |
Barclay A. Phillips SVP, Chief Financial Officer |
$1.12
CAGR »
|
$1,828.96 1,633 shares |
1-31-2017 Insider Buy |
John A. Herrmann III SVP, General Counsel |
$1.12
CAGR »
|
$5,555.20 4,960 shares |
12-7-2016 Insider Buy |
Gregory M. Glenn President, R&D |
$1.45
CAGR »
|
$1,446.00 1,000 shares |
9-21-2016 Insider Buy |
Gregory M. Glenn President, R&D |
$1.65
CAGR »
|
$1,649.00 1,000 shares |
9-21-2016 Insider Buy |
Michael A. McManus Jr. Director |
$1.61
CAGR »
|
$48,297.00 30,000 shares |
9-21-2016 Insider Buy |
Richard Douglas Director |
$1.72
CAGR »
|
$172,010.00 100,000 shares |
9-20-2016 Insider Buy |
Gail Boudreaux Director |
$1.45
CAGR »
|
$144,850.00 100,000 shares |
7-31-2016 Insider Buy |
Barclay A. Phillips SVP, Chief Financial Officer |
$4.29
CAGR »
|
$1,810.38 422 shares |
1-31-2016 Insider Buy |
Stanley C. Erck CEO and President |
$4.38
CAGR »
|
$9,075.36 2,072 shares |
1-31-2016 Insider Buy |
Barclay A. Phillips SVP, Chief Financial Officer |
$4.38
CAGR »
|
$1,773.90 405 shares |
1-31-2016 Insider Buy |
Gregory M. Glenn SVP, Research and Development |
$4.38
CAGR »
|
$10,376.22 2,369 shares |
1-31-2016 Insider Buy |
John A. Herrmann III SVP, General Counsel |
$4.38
CAGR »
|
$9,075.36 2,072 shares |
7-31-2015 Insider Buy |
Stanley C. Erck CEO and President |
$2.28
CAGR »
|
$7,311.96 3,207 shares |
7-31-2015 Insider Buy |
Barclay A. Phillips SVP, Chief Financial Officer |
$2.28
CAGR »
|
$1,741.92 764 shares |
7-31-2015 Insider Buy |
Stanley C. Erck CEO and President |
$2.28
CAGR »
|
$7,311.96 3,207 shares |
7-31-2015 Insider Buy |
Barclay A. Phillips SVP, Chief Financial Officer |
$2.28
CAGR »
|
$1,741.92 764 shares |
7-31-2015 Insider Buy |
Gregory M. Glenn SVP, Research and Development |
$2.28
CAGR »
|
$2,033.76 892 shares |
7-31-2015 Insider Buy |
John A. Herrmann III SVP, General Counsel |
$2.28
CAGR »
|
$3,424.56 1,502 shares |
7-31-2015 Insider Buy |
John Trizzino SVP, Commercial Operations |
$3.63
CAGR »
|
$18,505.74 5,098 shares |
1-31-2015 Insider Buy |
Stanley C. Erck CEO and President |
$2.28
CAGR »
|
$13,958.16 6,122 shares |
1-31-2015 Insider Buy |
Barclay A. Phillips SVP, Chief Financial Officer |
$2.28
CAGR »
|
$19,124.64 8,388 shares |
1-31-2015 Insider Buy |
Gregory M. Glenn SVP, Research and Development |
$2.28
CAGR »
|
$1,974.48 866 shares |
1-31-2015 Insider Buy |
Russell P. Wilson SVP, Business Development |
$2.28
CAGR »
|
$11,514.00 5,050 shares |
1-31-2015 Insider Buy |
Stanley C. Erck CEO and President |
$2.28
CAGR »
|
$13,958.16 6,122 shares |
1-31-2015 Insider Buy |
Barclay A. Phillips SVP, Chief Financial Officer |
$2.28
CAGR »
|
$19,124.64 8,388 shares |
1-31-2015 Insider Buy |
Gregory M. Glenn SVP, Research and Development |
$2.28
CAGR »
|
$1,974.48 866 shares |
1-31-2015 Insider Buy |
Russell P. Wilson SVP, Business Development |
$2.28
CAGR »
|
$11,514.00 5,050 shares |
1-31-2015 Insider Buy |
Timothy Jon Hahn SVP, Manufacturing |
$2.28
CAGR »
|
$21,270.12 9,329 shares |
1-31-2015 Insider Buy |
John A. Herrmann III SVP, General Counsel |
$2.28
CAGR »
|
$22,501.32 9,869 shares |
1-31-2015 Insider Buy |
John Trizzino SVP, Commercial Operations |
$3.63
CAGR »
|
$23,997.93 6,611 shares |
10-3-2014 Insider Buy |
Barclay A. Phillips SVP, Chief Financial Officer |
$4.11
CAGR »
|
$20,549.50 5,000 shares |
10-3-2014 Insider Buy |
Timothy Jon Hahn SVP, Manufacturing |
$4.05
CAGR »
|
$10,125.00 2,500 shares |
9-25-2014 Insider Buy |
Timothy Jon Hahn SVP, Manufacturing |
$4.17
CAGR »
|
$37,529.80 9,000 shares |
7-31-2014 Insider Buy |
Stanley C. Erck CEO and President |
$2.28
CAGR »
|
$15,476.64 6,788 shares |
7-31-2014 Insider Buy |
Barclay A. Phillips SVP, Chief Financial Officer |
$2.28
CAGR »
|
$20,036.64 8,788 shares |
7-31-2014 Insider Buy |
Russell P. Wilson SVP, Business Development |
$2.28
CAGR »
|
$11,374.92 4,989 shares |
7-31-2014 Insider Buy |
Gregory M. Glenn SVP, Research and Development |
$2.28
CAGR »
|
$28,971.96 12,707 shares |
7-31-2014 Insider Buy |
Timothy Jon Hahn SVP, Manufacturing & PD |
$2.28
CAGR »
|
$21,067.20 9,240 shares |
7-31-2014 Insider Buy |
John A. Herrmann III SVP, General Counsel |
$2.28
CAGR »
|
$20,406.00 8,950 shares |
6-17-2014 Insider Buy |
John Trizzino SVP, Commercial Operations |
$4.51
CAGR »
|
$24,799.50 5,500 shares |
6-16-2014 Insider Buy |
John Trizzino SVP, Commercial Operations |
$4.51
CAGR »
|
$74,454.20 16,500 shares |
3-25-2014 Insider Buy |
Richard Douglas Director |
$4.33
CAGR »
|
$216,700.00 50,000 shares |
3-25-2014 Insider Buy |
Stanley C. Erck CEO and President |
$4.27
CAGR »
|
$42,698.00 10,000 shares |
3-25-2014 Insider Buy |
Barclay A. Phillips SVP, Chief Financial Officer |
$4.25
CAGR »
|
$21,225.00 5,000 shares |
1-31-2014 Insider Buy |
Timothy Jon Hahn SVP, Manufacturing & PD |
$2.29
CAGR »
|
$21,562.64 9,416 shares |
1-31-2014 Insider Buy |
Gregory M. Glenn SVP, Research and Development |
$2.29
CAGR »
|
$9,393.58 4,102 shares |
1-31-2014 Insider Buy |
Russell P. Wilson SVP, Business Development |
$2.29
CAGR »
|
$11,221.00 4,900 shares |
6-12-2013 Insider Buy |
Richard Douglas Director |
$1.90
CAGR »
|
$95,000.00 50,000 shares |
6-10-2013 Insider Buy |
Timothy Jon Hahn SVP, Manufacturing & PD |
$1.88
CAGR »
|
$39,480.00 21,000 shares |
6-7-2013 Insider Buy |
Gregory M. Glenn Chief Scientific Officer |
$1.92
CAGR »
|
$3,840.00 2,000 shares |
3-11-2013 Insider Buy |
James F. Young Director |
$2.03
CAGR »
|
$203,000.00 100,000 shares |
5-14-2012 Insider Buy |
Timothy Jon Hahn SVP, Manufacturing & PD |
$1.33
CAGR »
|
$39,900.00 30,000 shares |
5-10-2012 Insider Buy |
Gregory M. Glenn Chief Scientific Officer |
$1.35
CAGR »
|
$33,750.00 25,000 shares |
4-10-2012 Insider Buy |
Richard Douglas Director |
$1.21
CAGR »
|
$60,500.00 50,000 shares |
12-1-2011 Insider Buy |
James F. Young Director |
$1.46
CAGR »
|
$292,000.00 200,000 shares |
12-5-2011 Insider Buy |
Gregory M. Glenn Chief Scientific Officer |
$1.50
CAGR »
|
$3,000.00 2,000 shares |
11-29-2011 Insider Buy |
Gregory M. Glenn Chief Scientific Officer |
$1.26
CAGR »
|
$2,520.00 2,000 shares |
8-19-2011 Insider Buy |
Stanley C. Erck President and CEO |
$1.26
CAGR »
|
$16,380.00 13,000 shares |
8-10-2011 Insider Buy |
Stanley C. Erck President and CEO |
$1.24
CAGR »
|
$62,000.00 50,000 shares |
8-9-2011 Insider Buy |
John Trizzino Snr. VP, Int & Govt Alliances |
$1.19
CAGR »
|
$23,800.00 20,000 shares |
8-9-2011 Insider Buy |
Frederick W. Driscoll VP, CFO & Treasurer |
$1.18
CAGR »
|
$23,600.00 20,000 shares |
8-9-2011 Insider Buy |
Richard Douglas Director |
$1.20
CAGR »
|
$60,000.00 50,000 shares |
6-20-2011 Insider Buy |
Richard Douglas Director |
$2.04
CAGR »
|
$101,750.00 50,000 shares |
8-25-2010 Insider Buy |
Gregory M. Glenn Chief Scientific Officer |
$2.01
CAGR »
|
$4,018.00 2,000 shares |
Also See: Institutional Holders of NVAX
Also See: SEC filings
Below we present the annualized performance delivered by NVAX stock since 3-10-2023 (the date of the most recent
insider purchase). The performance of the investment from the time NVAX insider buying occurred is the ultimate
test of whether insiders were right about NVAX being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/13/2023 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$6.85 |
|
End price/share: |
$4.09 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-40.29% |
|
Average Annual Total Return: |
-36.81% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$5,971.33 |
|
Years: |
1.12 |
|
NVAX Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent NVAX insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding NVAX
|
|